Drawing for OPSYNVI

USPTO serial 90165717

OPSYNVI

Reviewed by CopyMark Law Group

Reg. 7257052Status 700Registered
Filing date
Status date
Registration date
Jan 2, 2024
Examiner
MCCAULEY, BRENDAN D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OPSYNVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl Foytlin

Cheryl Foytlin JOHNSON & JOHNSONONE JOHNSON & JOHNSON PLAZANEW BRUNSWICK, NJ 08933UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectivesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2023ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Sep 14, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Sep 14, 2023PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Sep 14, 2023APETASSIGNED TO PETITION STAFF—
Aug 23, 2023IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 23, 2023TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Feb 16, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 14, 2023EX4GSOU EXTENSION 4 GRANTED—
Feb 14, 2023EXT4SOU EXTENSION 4 FILED—
Feb 14, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 21, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 19, 2022EX3GSOU EXTENSION 3 GRANTED—
Oct 19, 2022EXT3SOU EXTENSION 3 FILED—
Oct 19, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 7, 2022EX2GSOU EXTENSION 2 GRANTED—
Apr 7, 2022EXT2SOU EXTENSION 2 FILED—
Apr 7, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 6, 2021EX1GSOU EXTENSION 1 GRANTED—
Jul 6, 2021EXT1SOU EXTENSION 1 FILED—
Jul 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 20, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 23, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 23, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 3, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2021DOCKASSIGNED TO EXAMINER—
Oct 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance